News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
FDA approval: Zenocutuzumab for NRG1+ NSCLC – IASLC
The International Association for the Study of Lung Cancer/X
Jan 23, 2025, 16:29

FDA approval: Zenocutuzumab for NRG1+ NSCLC – IASLC

The International Association for the Study of Lung Cancer (IASLC) shared a post on X:

“ICYMI, the FDA recently approved zenocutuzumab for NSCLC with an NRG1 fusion.

Catch this all-new episode of Lung Cancer Considered as Stephen V Liu and Alison Schram discuss this breakthrough and what this approval means for treating NSCLC patients with an NRG1 fusion

Listen now.”

More posts featuring IASLC.

Alison Schram cancer FDA ICYMI Lung cancer NRG1 fusion NSCLC OncoDaily Oncology Stephen V Liu zenocutuzumab
Special Coverage
Blog
Apr 23, 2025, 17:17
Christian Ntizimira: Why does the African perspective in family meetings matter in oncology and palliative care?
Science
Apr 23, 2025, 17:13
International Consensus Statement on Diagnosis, Evaluation, and Research of Richter Transformation
Blog
Apr 23, 2025, 17:10
ESMO Living Guidelines for cutaneous melanoma
Blog
Apr 23, 2025, 17:03
City of Hope scientists and physicians will present their latest discoveries at the AACR Annual Meeting
Blog
Apr 23, 2025, 16:59
Michelle Mitchell: CRUK published report on UK-EU collaboration for global scientific research
Career
Apr 23, 2025, 16:51
Caryn Lerman: Yali Dou has been elected as a fellow of AAAS
Blog
Apr 23, 2025, 16:43
David Zaas: Proudly celebrated the ribbon-cutting of new Atrium Health Wake Forest Baptist Outpatient Surgery Center
Blog
Apr 23, 2025, 16:21
Alicia Zhou: Moderating CRI's dialogue on AI, data, and the future of cancer research
Blog
Apr 23, 2025, 16:21
Dolphins Cancer Challenge donates 100% of funds to Sylvester Comprehensive Cancer Center for cancer research
Blog
Apr 23, 2025, 16:12
The Spring 2025 edition of Oncolytics Today has arrived - NCODA
Blog
Apr 23, 2025, 16:07
Claudia Vasconcelos: DESTINY-Breast09 results could be practice-changing for patients with HER2+ MBC
Blog
Apr 23, 2025, 16:07
Suresh Ramalingam's work and Conquer Cancer's role in advancing cancer research